Abstract
A June 2012 meeting in Dublin, Ireland, showcased advances in the understanding of the role of IL-17 and related cytokines in host immunity and how these cytokines have been successfully targeted for the treatment of autoimmunity.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
Dermatology and Therapy Open Access 07 July 2022
-
NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Cancer Cell International Open Access 20 April 2021
-
Comparison of microglia and infiltrating CD11c+ cells as antigen presenting cells for T cell proliferation and cytokine response
Journal of Neuroinflammation Open Access 25 March 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cua, D.J. et al. Nature 421, 744–748 (2003).
Langrish, C.L. et al. J. Exp. Med. 201, 233–240 (2005).
Bettelli, E. et al. Nature 441, 235–238 (2006).
Mangan, P.R. et al. Nature 441, 231–234 (2006).
Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. Immunity 24, 179–189 (2006).
Sutton, C., Brereton, C., Keogh, B., Mills, K.H. & Lavelle, E.C. J. Exp. Med. 203, 1685–1691 (2006).
Ivanov, I.I. et al. Cell 126, 1121–1133 (2006).
Sutton, C.E. et al. Immunity 31, 331–341 (2009).
Chen, K. et al. Immunity 35, 997–1009 (2011).
Hernández-Santos, N. & Gaffen, S.L. Cell Host Microbe 11, 425–435 (2012).
Zelante, T., et al. Nat. Commun. 3, 683 (2012).
Sonnenberg, G.F. et al. Science 336, 1321–1325 (2012).
Esplugues, E. et al. Nature 475, 514–518 (2011).
Li, Y. et al. Cell 147, 629–640 (2011).
Flanagan, K. et al. PLoS ONE 7, e40443 (2012).
Hueber, W. et al. Gut published online, doi:10.1136/gutjnl-2011-301668 (17 May 2012).
Rahman, P. et al. J. Rheumatol. 36, 137–140 (2009).
Kenna, T.J. et al. Arthritis Rheum. 64, 1420–1429 (2012).
Ruutu, M. et al. Arthritis Rheum. 64, 2211–2222 (2012).
Schnyder-Candrian, S. et al. J. Exp. Med. 203, 2715–2725 (2006).
Marshall, N.A. et al. Cancer Res. 72, 581–591 (2012).
Leonardi, C.L. et al. Lancet 371, 1665–1674 (2008).
Papp, K.A. et al. Lancet 371, 1675–1684 (2008).
Leonardi, C. et al. N. Engl. J. Med. 366, 1190–1199 (2012).
Acknowledgements
We thank all presenters at the conference for their contributions and apologize to all whose work was not included because of space constraints. The conference was held under the auspices of the International Cytokine Society at the Trinity Biomedical Sciences Institute, Trinity College, Dublin, and was organized by K. Mills and D. Cua, with assistance from Julie-Ann O'Reilly. We thank the following sponsors: Science Foundation Ireland, BioLegend, eBioscience, BioRad, Randox, Abcam, MabTech, PeproTech, R&D Systems, Pfizer, Abbott, Amgen, Cell Press/Elsevier, MedImmune, Merck Sharp & Dohme and the Irish Tourist Board.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
K.H.G.M. is the cofounder of and a shareholder in Opsona Therapeutics and TriMod Therapeutics, which are start-up companies involved in the development of immunotherapeutics. D.C. is an employee of Merck.
Rights and permissions
About this article
Cite this article
Jones, S., Sutton, C., Cua, D. et al. Therapeutic potential of targeting IL-17. Nat Immunol 13, 1022–1025 (2012). https://doi.org/10.1038/ni.2450
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2450
This article is cited by
-
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
Dermatology and Therapy (2022)
-
NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Cancer Cell International (2021)
-
New answers to old problems
Nature Reviews Rheumatology (2016)
-
Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists
Nature Chemical Biology (2015)
-
Identification of the salmonid IL-17A/F1a/b, IL-17A/F2b, IL-17A/F3 and IL-17N genes and analysis of their expression following in vitro stimulation and infection
Immunogenetics (2015)